Ideas February 4, 2021

A traditional monthly report on the portfolio - in Intelinvest and Google table...

Good afternoon!

Traditional Monthly Portfolio Report - Intelinvest and a Google Sheet

Completed transactions - on 26.01, I bought 22 stocks of Baozun for $35.99 and 27 stocks of Zynex for $18.99.

Among the important events is certainly the growth of TCSG to 3000 RUB+ per share. In a review in March 2020, I set a goal of 2500 RUB (+150%) with a horizon until the end of 2022. From the current levels, it certainly seems quite real, but at the time of writing the review, the stock was 934 RUB, and the 2500+ target was quite ambitious. With this, I want to say that with a good choice of stocks for investment and a good entry point, the growth potential can be higher than expected. If we consider moderately or fast-growing companies, I see no point in taking profits on them as long as the indicators remain consistently good and profits grow. Tinkoff certainly had a great year, unlike, for example, Sberbank, which is praised by investment channels, but I do not see much positive about it - the stocks rose, and profit in annual terms fell by ~10%.Tinkoff for 19 year earned 36 billion, for 20 the forecast is about 44 billion (probably in fact it will be higher). It is also likely to be included in the index in the spring or later, which can lead to a repetition of the history with Yandex (purchases of funds that repeat the indexes), and the longs of speculators who buy stupidly everything that grows - all this can become an additional driver. Based on this, I do not touch the positions on TCS and TCSG, and if you have securities in your portfolio purchased below 2000 RUB on TCSG, I also recommend holding them calmly.

We are waiting for the Baozun report on March 16, the stocks have already got out for $40 on the news, but I certainly expect more. After the purchase of 26.01, the company is in the first place in my portfolio, the weight is about 22%.

Zynex took the 4th place in the portfolio after the price increase and my purchases, I also have high hopes for the company in 21-22, but I do not recommend buying above $20 (I have 66 stocks with an average of $16.06).